PL2521562T3 - Ev576 do zastosowania w leczeniu zakażeń wirusowych dróg oddechowych - Google Patents
Ev576 do zastosowania w leczeniu zakażeń wirusowych dróg oddechowychInfo
- Publication number
- PL2521562T3 PL2521562T3 PL11700973T PL11700973T PL2521562T3 PL 2521562 T3 PL2521562 T3 PL 2521562T3 PL 11700973 T PL11700973 T PL 11700973T PL 11700973 T PL11700973 T PL 11700973T PL 2521562 T3 PL2521562 T3 PL 2521562T3
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- respiratory tract
- viral infections
- infections
- viral
- Prior art date
Links
- 208000036142 Viral infection Diseases 0.000 title 1
- 210000002345 respiratory system Anatomy 0.000 title 1
- 230000009385 viral infection Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1000318.4A GB201000318D0 (en) | 2010-01-08 | 2010-01-08 | Method of treatment |
| GBGB1005071.4A GB201005071D0 (en) | 2010-03-25 | 2010-03-25 | Method of treatment |
| PCT/GB2011/000022 WO2011083317A1 (en) | 2010-01-08 | 2011-01-10 | Ev576 for use in the treatment of viral infections of the respiratory tract |
| EP11700973.8A EP2521562B1 (en) | 2010-01-08 | 2011-01-10 | Ev576 for use in the treatment of viral infections of the respiratory tract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2521562T3 true PL2521562T3 (pl) | 2020-04-30 |
Family
ID=44305222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11700973T PL2521562T3 (pl) | 2010-01-08 | 2011-01-10 | Ev576 do zastosowania w leczeniu zakażeń wirusowych dróg oddechowych |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US20120283167A1 (enExample) |
| EP (1) | EP2521562B1 (enExample) |
| JP (1) | JP5840623B2 (enExample) |
| CN (1) | CN102762223B (enExample) |
| AU (2) | AU2011204483B2 (enExample) |
| CA (1) | CA2785612C (enExample) |
| NZ (1) | NZ601018A (enExample) |
| PL (1) | PL2521562T3 (enExample) |
| WO (1) | WO2011083317A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116785426A (zh) * | 2014-03-20 | 2023-09-22 | 因弗拉克斯有限责任公司 | 用于治疗病毒性肺炎的C5a抑制剂 |
| GB201410116D0 (en) * | 2014-06-06 | 2014-07-23 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| GB201602802D0 (en) | 2016-02-17 | 2016-03-30 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| EP4374922A3 (en) | 2016-06-14 | 2024-08-28 | Regeneron Pharmaceuticals, Inc. | Anti-c5 antibodies and uses thereof |
| DK3612208T5 (da) | 2017-04-21 | 2024-09-02 | Volution Immuno Pharmaceuticals Sa | Coversin til behandlingen af autoimmune sygdomme med blisterdannelse |
| SG11202004662RA (en) | 2017-12-13 | 2020-06-29 | Regeneron Pharma | Anti-c5 antibody combinations and uses thereof |
| CN112203679A (zh) | 2018-03-02 | 2021-01-08 | 科达制药股份有限公司 | Il-6抗体及其融合构建体和缀合物 |
| US20220047673A1 (en) * | 2018-09-10 | 2022-02-17 | Volution Immuno Pharmaceuticals Sa | Coversin for Use in the Treatment of Rheumatic Diseases |
| GB201905810D0 (en) * | 2019-04-25 | 2019-06-05 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| US12097222B2 (en) | 2019-06-06 | 2024-09-24 | Spiritus Therapeutics, Inc. | Methods for attenuating viral infection and for treating lung injury |
| WO2020247675A1 (en) * | 2019-06-06 | 2020-12-10 | Spiritus Therapeutics, Inc. | Methods for attenuating viral infection and for treating lung injury |
| WO2020247610A1 (en) | 2019-06-06 | 2020-12-10 | Spiritus Therapeutics, Inc. | Mesenchymal stem cell-derived extracellular vesicles and uses thereof for treating and diagnosing fibrotic diseases |
| AU2019468121A1 (en) | 2019-09-27 | 2022-05-12 | Volution Immuno Pharmaceuticals Sa | Method of treatment of hematopoietic stem cell transplant associated thrombotic microangiopathy (HSCT-TMA) |
| CN114786731A (zh) | 2019-10-10 | 2022-07-22 | 科达制药股份有限公司 | 治疗眼部病症的方法 |
| CN115884764A (zh) * | 2020-04-01 | 2023-03-31 | 硫创治疗公司 | 用于治疗乙型冠状病毒感染的半胱胺前体化合物 |
| WO2021226404A1 (en) * | 2020-05-08 | 2021-11-11 | Kodiak Sciences Inc. | Use of il-6 antibodies and vegf traps, and fusion constructs and conjugates thereof |
| GB202218084D0 (en) | 2022-12-01 | 2023-01-18 | Volution Immuno Pharmaceuticals Sa | Fusion proteins |
| GB202408081D0 (en) | 2024-06-06 | 2024-07-24 | Volution Immuno Pharmaceuticals Sa | Methods of removing impurities |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3734093A (en) | 1992-02-27 | 1993-09-13 | Merck & Co., Inc. | Protein for inhibiting collagen-stimulated platelet aggregation |
| US7884066B2 (en) | 1999-10-05 | 2011-02-08 | The Regents Of The University Of California | NELL-1 enhanced bone mineralization |
| US7785601B2 (en) | 2002-12-31 | 2010-08-31 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
| MXPA05012880A (es) * | 2003-06-02 | 2006-02-22 | Evolutec Ltd | Inhibidores de complemento. |
| GB0518443D0 (en) | 2005-09-09 | 2005-10-19 | Evolutec Ltd | Method of treating myasthenia gravis |
| US7274999B1 (en) * | 2006-03-10 | 2007-09-25 | Atmel Corporation | Brownout detector system and method |
| CA2649090A1 (en) * | 2006-04-12 | 2007-10-18 | Biocryst Pharmaceuticals, Inc. | Intramuscular antiviral treatments |
| JP2010502687A (ja) * | 2006-09-08 | 2010-01-28 | ヴァーレイ・リミテッド | 呼吸器疾患の治療方法 |
| GB0617734D0 (en) * | 2006-09-08 | 2006-10-18 | Evolutec Ltd | Method of treating peripheral nerve disorders |
| GB0802116D0 (en) * | 2008-02-05 | 2008-03-12 | Natural Enviromental Res Counc | Treatment |
-
2011
- 2011-01-10 CN CN201180005464.6A patent/CN102762223B/zh active Active
- 2011-01-10 JP JP2012547546A patent/JP5840623B2/ja active Active
- 2011-01-10 WO PCT/GB2011/000022 patent/WO2011083317A1/en not_active Ceased
- 2011-01-10 PL PL11700973T patent/PL2521562T3/pl unknown
- 2011-01-10 US US13/521,011 patent/US20120283167A1/en not_active Abandoned
- 2011-01-10 CA CA2785612A patent/CA2785612C/en active Active
- 2011-01-10 NZ NZ601018A patent/NZ601018A/xx not_active IP Right Cessation
- 2011-01-10 EP EP11700973.8A patent/EP2521562B1/en active Active
- 2011-01-10 AU AU2011204483A patent/AU2011204483B2/en active Active
-
2015
- 2015-01-02 US US14/588,616 patent/US9522171B2/en active Active
-
2016
- 2016-05-11 AU AU2016203058A patent/AU2016203058B2/en active Active
- 2016-07-22 US US15/217,601 patent/US20170065677A1/en not_active Abandoned
-
2019
- 2019-06-07 US US16/434,737 patent/US20200155646A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20200155646A1 (en) | 2020-05-21 |
| US20120283167A1 (en) | 2012-11-08 |
| JP2013516450A (ja) | 2013-05-13 |
| AU2016203058B2 (en) | 2018-01-18 |
| EP2521562B1 (en) | 2019-09-18 |
| US20150196619A1 (en) | 2015-07-16 |
| AU2011204483A1 (en) | 2012-07-12 |
| US9522171B2 (en) | 2016-12-20 |
| US20170065677A1 (en) | 2017-03-09 |
| JP5840623B2 (ja) | 2016-01-06 |
| CA2785612A1 (en) | 2011-07-14 |
| AU2016203058A1 (en) | 2016-06-02 |
| CN102762223B (zh) | 2014-09-03 |
| CN102762223A (zh) | 2012-10-31 |
| NZ601018A (en) | 2013-09-27 |
| WO2011083317A1 (en) | 2011-07-14 |
| AU2011204483B2 (en) | 2016-02-11 |
| EP2521562A1 (en) | 2012-11-14 |
| CA2785612C (en) | 2019-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2521562T3 (pl) | Ev576 do zastosowania w leczeniu zakażeń wirusowych dróg oddechowych | |
| HUS2400017I1 (hu) | Dolutegravir és lamivudin kombinációi HIV-fertõzés kezelésére | |
| SI2627334T1 (sl) | Sestavki za uporabo pri zdravljenju virusnih infekcij | |
| ZA201500921B (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diaseases | |
| IL232046A (en) | Furein derivatives for the treatment of viral infections | |
| ZA201308746B (en) | Quinazoline derivatives for the treatment of viral infections and further diseases | |
| ZA201502238B (en) | Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases | |
| IL222333A0 (en) | Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract | |
| GB201002243D0 (en) | Respiratory disease treatment | |
| PL2903608T3 (pl) | Kompozycja farmaceutyczna obejmująca kwas propionowy do stosowania w leczeniu infekcji wirusowych | |
| GB201002224D0 (en) | Respiratory disease treatment | |
| LT2544705T (lt) | Interferono beta panaudojimas gripo sukeltų apatinių kvėpavimo takų ligų gydymui | |
| ZA201306342B (en) | The treatment of viral infections | |
| GB201012168D0 (en) | Treatment of viral infections | |
| GB201001821D0 (en) | Treatment of viral infections | |
| GB2477540A8 (en) | Respiratory disease treatment | |
| GB201002235D0 (en) | Respiratory disease treatment | |
| GB201001903D0 (en) | Respiratory disease treatment | |
| SI2315580T1 (sl) | Farmacevtski pripravki in postopki za zdravljenjeinfekcij respiratornega trakta | |
| GB0913914D0 (en) | Treatment of viral infections | |
| GB0919711D0 (en) | Treatment of viral infections |